Clozapine increases cutaneous blood flow and reduces sympathetic cutaneous vasomotor alerting responses (SCVARs) in rats: Comparison with effects of haloperidol

Psychopharmacology

Volumn 181, Issue 3, 2005, Pages 518-528

  Blessing, William Walter ^a,b  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

5 HT 2A receptors; 5 HT1A receptors; 8 OH DPAT; Body temperature; Dopamine D1 receptors; Dopamine D2 receptors; L741,626; SCH23390; Schizophrenia; SR46349B

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CLOZAPINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; EPLIVANSERIN; HALOPERIDOL; L 471 626; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; DOPPLER FLOWMETER; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; EMOTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; SKIN BLOOD FLOW; STIMULUS RESPONSE; SYMPATHETIC TONE; VASOMOTOR REFLEX;

ANIMALS; ANTIPSYCHOTIC AGENTS; AROUSAL; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOPERIDOL; INJECTIONS, SUBCUTANEOUS; LASER-DOPPLER FLOWMETRY; LIPOPOLYSACCHARIDES; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; SKIN; SKIN TEMPERATURE; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION; VASOMOTOR SYSTEM;

EID: 26944447079     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0012-9     Document Type: Article

References (63)

1. Ackner B (1956) Emotions and the peripheral vasomotor system. J Psychosom Res 1:3-20
2. Arnt J, Skarsfeldt T (1998) Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18:63-101
3. Arvidsson LE, Johansson AM, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Magnusson T, Carlsson A, Andersson B, Wikstrom H (1987) (+)-cis-8-Hydroxy-1- methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist. J Med Chem 30:2105-2109
4. Bantick RA, Deakin JF, Grasby PM (2001) The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics? J Psychopharmacol 15:37-46
5. Blessing WW (2004a) 5-Hydroxytryptamine 1A receptor activation reduces cutaneous vasoconstriction and fever associated with the acute inflammatory response in rabbits. Neuroscience 123:1-4
6. Blessing WW (2004b) Clozapine and olanzapine, but not haloperidol, reverse cold-induced and lipopolysaccharide-induced cutaneous vasoconstriction. Psychopharmacology (Berl) 175:487-493
7. 2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats. Neuroscience 117:939-948
8. Blessing WW, Arnolda LF, Yu YH (1998) Cutaneous vasoconstriction with alerting stimuli in rabbits reflects a patterned redistribution of cardiac output. Clin Exp Pharmacol Physiol 25:457-460
9. Blessing WW, Seaman B, Pedersen NP, Ootsuka Y (2003) Clozapine reverses hyperthermia and sympathetically-mediated cutaneous vasoconstriction induced by MDMA (Ecstasy) in rabbits and rats. J Neurosci 23:6385-6391
10. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87-96
11. 4 receptors. Neuropharmacology 44:1047-1053
12. Chung YC, Li Z, Dai J, Meltzer HY, Ichikawa J (2004) Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism. Brain Res 1023:54-63
13. Cryan JF, Kelliher P, Kelly JP, Leonard BE (1999) Comparative effects of serotonergic agonists with varying efficacy at the 5-HT(1A) receptor on core body temperature: modification by the selective 5-HT(1A) receptor antagonist WAY 100635. J Psychopharmacol 13:278-283
14. Davis JM, Chen N (2004) Dose response and dose equivalence of antipsychotics. J Clin Psychopharmacol 24:192-208
15. Delius W, Hagbarth K-E, Hongell A, Wallin BG (1972) Manoeuvres affecting sympathetic outflow in human skin nerves. Acta Physiol Scand 84:177-186
16. Faunt JE, Crocker AD (1987) The effects of selective dopamine receptor agonists and antagonists on body temperature in rats. Eur J Pharmacol 133:243-247
17. Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A (1995) A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Eur J Pharmacol 281:81-88
18. Garcia JN, Pedersen NP, Nalivaiko E, Blessing WW (2001) Tail artery blood flow measured by chronically implanted Doppler ultrasonic probes in unrestrained conscious rats. J Neurosci Methods 104:209-213
19. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156:117-154
20. Gudelsky GA, Koenig JI, Meltzer HY (1986) Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors. Neuropharmacology 25:1307-1313
21. Hagbarth K-E, Hallin RG, Hongell A, Torebjörk HE, Wallin BG (1972) General characteristics of sympathetic activity in human skin nerves. Acta Physiol Scand 84:164-172
22. Hartman D, Monsma F, Civelli O (1996) Interaction of antipsychotic drugs with dopamine receptor subtypes. In: Csernansky JG (ed) Handbook of experimental pharmacology. Springer, Berlin Heidelberg New York, pp 43-75
23. Heh CW, Herrera J, DeMet E, Potkin S, Costa J, Sramek J, Hazlett E, Buchsbaum MS (1988) Neuroleptic-induced hypothermia associated with amelioration of psychosis in schizophrenia. Neuropsychopharmacology 1:149-156
24. Jacob J, Lafille C (1963) Charactérisation et detection pharacologiques des substances hallucinogènes. Arch Int Pharmacodyn 145:528-545
25. Kapur S, Seeman P (2001) Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry 158:360-369
26. Kistler A, Mariauzouls C, von Berlepsch K (1998) Fingertip temperature as an indicator for sympathetic responses. Int J Psychophysiol 29:35-41
27. Krogh A (1922) The anatomy and physiology of capillaries, 2nd edn. Yale University Press, New Haven, CT
28. Kulagowski JJ, Broughton HB, Curtis NR, Mawer IM, Ridgill MP, Baker R, Emms F, Freedman SB, Marwood R, Patel S, Ragan CI, Leeson PD (1996) 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor. J Med Chem 39:1941-1942
29. Macefield VG, Wallin BG (1999) Respiratory and cardiac modulation of single sympathetic vasoconstrictor and sudomotor neurones to human skin. J Physiol 516(Pt 1):303-314
30. Martin KF, Phillips I, Hearson M, Prow MR, Heal DJ (1992) Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants. Br J Pharmacol 107:15-21
31. Meltzer HY (2002) Commentary on "clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia" (Psychopharmacology (1989) 99: S18-S27). Psychopharmacology (Berl) 163:1-3
32. Meltzer HY, Li Z, Kaneda Y, Ichikawa J (2003) Serotonin receptors: their key role in drugs to treat schizophrenia. Prog NeuroPsychopharmacol Biol Psychiatry 27:1159-1172
33. Meltzer HY, Arvanitis L, Bauer D, Rein W (2004) Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder. Am J Psychiatry 161:975-984
34. Mendoza DL, Bravo HA, Swanson HH (1999) Antiaggresive and anxiolytic effects of gepirone in mice, and their attenuation by WAY 100635. Pharmacol Biochem Behav 62:499-509
35. Millan MJ (2000) Improving the treatment of schizophrenia: focus on serotonin (5-HT1A) receptors. J Pharmacol Exp Ther 295:853-861
36. Millan MJ, Rivet JM, Canton H, Le Marouille-Girardon S, Gobert A (1993) Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. J Pharmacol Exp Ther 264:1364-1376
37. Millan MJ, Audinot V, Melon C, Newman-Tancredi A (1995) Evidence that dopamine D3 receptors participate in clozapine-induced hypothermia. Eur J Pharmacol 280:225-229
38. Nash JF, Meltzer HY, Gudelsky GA (1988) Antagonism of serotonin receptor mediated neuroendocrine and temperature responses by atypical neuroleptics in the rat. Eur J Pharmacol 151:463-469
39. Oerther S, Ahlenius S (2000) Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat. J Pharmacol Exp Ther 292:731-736
40. Olivier B, Molewijk E, van Oorschot R, van der Poel G, Zethof T, van der Heyden J, Mos J (1994) New animal models of anxiety. Eur Neuro-Psychopharmacol 4:93-102
41. Ootsuka Y, Blessing WW (2003) 5-Hydroxytryptamine 1A receptors inhibit cold-induced sympathetically-mediated cutaneous vasoconstriction in rabbits. J Physiol 552.1:303-314
42. Ootsuka Y, Blessing W (2005) Activation of slowly conducting medullary raphé-spinal neurons, including serotonergic neurons, increases cutaneous sympathetic vasomotor in rabbit. Am J Physiol 288:R909-R918
43. 2A receptors regulate cutaneous sympathetic vasomotor outflow in rabbits and rats; relevance for cutaneous vasoconstriction elicited by MDMA (3,4- methylenedioxymethamphetamine, "Ecstasy") and its reversal by clozapine. Brain Res 1014:34-44
44. Pattij T, Groenink L, Hijzen TH, Oosting RS, Maes RA, van der Gugten J, Olivier B (2002) Autonomic changes associated with enhanced anxiety in 5-HT(1A) receptor knockout mice. Neuropsychopharmacology 27:380-390
45. Pedersen NP, Blessing WW (2001) Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits. J Neurosci 21:8648-8654
46. Rigdon GC, Weatherspoon JK (1992) 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp Ther 263:486-493
47. Rinaldi-Carmona M, Congy C, Santucci V, Simiand J, Gautret B, Neliat G, Labeeuw B, Le Fur G, Soubrie P, Breliere JC (1992) Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist. J Pharmacol Exp Ther 262:759-768
48. 1 receptor agonist. Eur J Pharmacol 307:27-31
49. 2 receptors in the regulation of body temperature in the rat. Eur J Pharmacol 236:395-400
50. Salmi P, Karlsson T, Ahlenius S (1994) Antagonism by SCH 23390 of clozapine-induced hypothermia in the rat. Eur J Pharmacol 253:67-73
51. Schmidt CJ, Black CK, Abbate GM, Taylor VL (1990) Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors. Brain Res 529:85-90
52. Shiloh R, Weizman A, Epstein Y, Rosenberg SL, Valevski A, Dorfman-Etrog P, Wiezer N, Katz N, Munitz H, Hermesh H (2001) Abnormal thermoregulation in drug-free male schizophrenia patients. Eur Neuropsychopharmacol 11:285-288
53. Shiloh R, Portuguese S, Bodinger L, Katz N, Sigler M, Hermesh H, Munitz H, Weizman A (2003) Increased corneal temperature in drug-free male schizophrenia patients. Eur Neuropsychopharmacol 13:49-52
54. 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction. Brain Res 1028:191-202
55. Tauscher J, Hussain T, Agid O, Verhoeff NP, Wilson AA, Houle S, Remington G, Zipursky RB, Kapur S (2004) Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. Am J Psychiatry 161:1620-1625
56. van den Buuse M (2003) Acute effects of antipsychotic drugs on cardiovascular responses to stress. Eur J Pharmacol 464:55-62
57. Van der Heyden JA, Zethof TJ, Olivier B (1997) Stress-induced hyperthermia in singly housed mice. Physiol Behav 62:463-470
58. Wallin BG, Fagius J (1988) Peripheral sympathetic neural activity in conscious humans. Annu Rev Physiol 50:565-576
59. 2A receptor inverse agonists as antipsychotics. J Pharmacol Exp Ther 299:268-276
60. Young AH, McShane R, Park SB, Cowen PJ (1993) Buspirone-induced hypothermia in normal male volunteers. Biol Psychiatry 34:665-666
61. Yu YH, Blessing WW (1997) Cutaneous vasoconstriction in conscious rabbits during alerting responses detected by hippocampal theta-rhythm. Am J Physiol 272:R208-R216
62. Zahn TP, Pickar D (1993) Autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine. Biol Psychiatry 34:3-12
63. Zethof TJ, Van der Heyden JA, Tolboom JT, Olivier B (1995) Stress-induced hyperthermia as a putative anxiety model. Eur J Pharmacol 294:125-135